Pinealon
Mechanism.
Pinealon is a synthetic tripeptide (Glu-Asp-Arg, or EDR) developed by Russian gerontologist Vladimir Khavinson as part of his bioregulatory peptide program. It is designed to mimic peptides naturally derived from the pineal gland and is proposed to have neuroprotective and geroprotective properties. Research is primarily from Russian institutions and consists mostly of in vitro and animal studies with limited clinical data.
Pinealon is like a short text message sent to your brain cells' genetic instruction manual, nudging them to keep running their protective and repair programs. Think of it as a tiny molecular reminder to your neurons to stay in maintenance mode rather than shutting down.
How it's taken.
Values below describe how Pinealon has been administered in published trials and labeling. Provided for educational purposes only — this is not medical advice and not instructions for self-administration. Consult your healthcare provider before making any health decision.
Khavinson tripeptide (Glu-Asp-Arg) bioregulator targeting CNS/pineal gland. Based on Russian bioregulatory peptide protocols. No FDA-approved indication. Available as supplement in some markets.
Use the free peptide calculator for dilution, unit conversion, and injection volume.
Side effects, rare serious events, who shouldn't.
Every study we cite.
Each study with its published finding and a plain-language note on limitations or funding.